Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
39.56 EUR | +5.14% | +1.96% | -16.20% |
01:37pm | ABL Bio, BMS Collaborate on Gastric Cancer Treatment Trial | MT |
Jun. 07 | Geron shares surge after U.S. FDA approves blood disorder drug | RE |
Sales 2024 * | 46.09B 42.82B | Sales 2025 * | 46.06B 42.79B | Capitalization | 84.08B 78.12B |
---|---|---|---|---|---|
Net income 2024 * | -5.41B -5.03B | Net income 2025 * | 10.22B 9.5B | EV / Sales 2024 * | 2.67 x |
Net Debt 2024 * | 39.03B 36.27B | Net Debt 2025 * | 31.68B 29.43B | EV / Sales 2025 * | 2.51 x |
P/E ratio 2024 * |
-15.8
x | P/E ratio 2025 * |
7.85
x | Employees | 34,100 |
Yield 2024 * |
5.8% | Yield 2025 * |
6.09% | Free-Float | 69.27% |
Latest transcript on Bristol-Myers Squibb Company
1 day | +5.14% | ||
1 week | +1.96% | ||
Current month | +2.86% | ||
1 month | -6.15% | ||
3 months | -21.82% | ||
6 months | -16.83% | ||
Current year | -16.20% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 53 | 15-01-31 | |
David Elkins
DFI | Director of Finance/CFO | 55 | 19-11-19 |
Greg Meyers
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Phyllis Yale
BRD | Director/Board Member | 66 | 19-11-19 |
Peter Arduini
BRD | Director/Board Member | 59 | 16-03-31 |
Derica Rice
BRD | Director/Board Member | 59 | 20-08-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-10 | 39.05 | +3.77% | 180 |
24-06-07 | 37.63 | -0.19% | 0 |
24-06-06 | 37.7 | -0.79% | 1,530 |
24-06-05 | 38 | -1.40% | 1,100 |
24-06-04 | 38.54 | +0.63% | 1,934 |
Delayed Quote Deutsche Boerse AG, June 10, 2024 at 10:00 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+48.38% | 765B | |
-6.19% | 354B | |
+20.63% | 331B | |
+10.05% | 299B | |
+18.87% | 248B | |
-1.96% | 219B | |
+11.11% | 216B | |
+5.71% | 164B | |
-2.43% | 162B |
- Stock Market
- Equities
- BMY Stock
- BRM Stock